Home›Companies›Healthcare›Atraverse Medical

Atraverse Medical, Inc.

Updated Oct 27, 2026·Latest SEC filing May 7, 2025·Suggest an edit

About Atraverse Medical

Atraverse Medical is a private company based in Cardiff by the Sea, California, incorporated in 2022 in Delaware. It has reported $33,134,680 raised in five offerings on Form D since February 2023. Its chief executive is John Slump.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 23, 2025May 7, 2025$8,630,200of $10.0M target41$210KConvertible Promissory Notes and equity securities issuable upon conversion thereofRule 506(b)Form D ↗
Feb 13, 2025Feb 26, 2025$15,000,000fully sold1$15.0MDebt, Convertible Promissory Note and equity securities issuable upon conversion thereofRule 506(b)Form D ↗
Jul 31, 2024Aug 13, 2024$4,104,480of $5.0M target33$124KDebt, OptionsRule 506(b)Form D ↗
Oct 24, 2023Nov 2, 2023$400,000of $3.0M target1$400KEquityRule 506(b)Form D ↗
Feb 3, 2023Feb 16, 2023amended Nov 22, 2023$5,000,000fully sold32$156KEquityRule 506(b)Form D/A ↗1 earlier filing
Total, five offerings$33,134,680

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Atraverse Medical's Form D filed May 7, 2025.

ES
Eric Sauter
Executive officer, director and promoter
JS
John Slump
Chief Executive Officer and director
SM
Steven Mickelsen
Executive officer, director and promoter

Sources

  1. SECAtraverse Medical, Inc. Form D, filed Feb 16, 2023
  2. SECAtraverse Medical, Inc. filing history